Public

Carahsoft Named Google Cloud’s Global Public Sector Partner of the Year for 2024

Retrieved on: 
Tuesday, April 9, 2024
Cloud, Google Cloud, Conference, Public, ISV, Trust (social science), Government agency, Public sector, Carahsoft, Ecosystem, FedRAMP, Marketing, Corporation, Network equipment provider

RESTON, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp. , The Trusted Government IT Solutions Provider®, today announced that it has received the 2024 Google Cloud Global Public Sector Partner of the Year Award.

Key Points: 
  • RESTON, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp. , The Trusted Government IT Solutions Provider®, today announced that it has received the 2024 Google Cloud Global Public Sector Partner of the Year Award.
  • The award was announced on the Google Cloud blog , and at the 2024 Google Cloud Next Conference , and highlights Carahsoft’s exceptional dedication to fostering customer relationships and cultivating a robust partner ecosystem crucial for Google Cloud’s success in the Public Sector.
  • “We're proud to announce Carahsoft as a 2024 Google Cloud Partner Award winner and recognize their achievements enabling customer success from the past year.”
    As Google Cloud’s Public Sector Distributor since 2015, Carahsoft remains committed to enhancing Google Cloud’s presence within the Public Sector through its multifaceted approach.
  • “Carahsoft is honored to receive Google Cloud’s 2024 Global Public Sector Partner of the Year Award,” said Terry Drinkwine, Vice President at Carahsoft.

Lava for Good Podcasts Garners Webby Nominations for 'The War on Drugs' and Honors for 'Earwitness'

Retrieved on: 
Thursday, April 4, 2024
War on Drugs, Webby Awards, Depression, Music, Partnership, Name, Public, Dignity, Humour, Human, Season, Season 2, Justice, War, Good, Pain management, Legislation, Sport, Miscarriage, Public service, PTSD, Entertainment

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Lava for Good Podcasts is honored by the latest accolades in the digital world.

Key Points: 
  • NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Lava for Good Podcasts is honored by the latest accolades in the digital world.
  • The latest recognition for The War on Drugs is particularly timely, as Lava for Good has commenced production of Season 2 for release this fall.
  • These nominations and honors add to Lava for Good’s long list of accolades, including past recognition at the Webby Awards, Ambie Awards, Signal Awards, and iHeartPodcast Awards.
  • For more information on The War on Drugs, Earwitness, and other Lava for Good podcasts, visit www.lavaforgood.com or find them on all popular podcast platforms.

Trellis Data and Carahsoft Partner to Bring AI Solutions for Secure Data Management and Storage to the Public Sector

Retrieved on: 
Thursday, April 4, 2024
Organization, Public, IBM PS/ValuePoint, Trust (social science), Partnership, Universal translator, Information technology, Trellis, AI, Public sector, Carahsoft, Translation, NASA, Language, National Association, Privacy, Data management, Artificial intelligence, State

“We’re excited to partner with Carahsoft and to bring our cutting-edge AI solutions to the Public Sector,” said Shane Doyle, Director of Sales for Trellis Data USA.

Key Points: 
  • “We’re excited to partner with Carahsoft and to bring our cutting-edge AI solutions to the Public Sector,” said Shane Doyle, Director of Sales for Trellis Data USA.
  • “Trellis Data is at the forefront of developing powerful AI technologies and integrating them into large-scale operations.
  • “We are pleased to add Trellis Data’s Secure Chat and Speech solutions to Carahsoft’s Artificial Intelligence and Machine Learning portfolio,” said Michael Adams, Program Executive for AI Solutions at Carahsoft.
  • For more information, contact the Carahsoft Team at (888) 606-2770 or [email protected] ; or register for a demo to see Trellis Data in action.

New Survey Reveals Present-Day Risks of Asbestos Exposure in America - 38% in High-Risk Jobs, 47% Vulnerable through Second-Hand Exposure

Retrieved on: 
Thursday, April 4, 2024
Law, Asbestos, Risk, Education, Lung, Public, PLLC, Cancer, Mesothelioma, EPA, Sickness, Gen

These findings, released today, underscore the urgent necessity for Asbestos Cancer Risk Awareness and routine testing.

Key Points: 
  • These findings, released today, underscore the urgent necessity for Asbestos Cancer Risk Awareness and routine testing.
  • They emphasize the crucial importance of proactive measures to mitigate the pervasive risks associated with asbestos exposure in the United States.
  • Awareness about the risks of asbestos exposure appears to be widespread, with 45% of respondents acknowledging the potential dangers.
  • For more information on asbestos risks and testing, including an infographic, podcast, and video, visit this page .

TearSolutions, Inc. Appoints Louis M Alpern, MD, MPH, FACS, FICS to its Board of Directors

Retrieved on: 
Wednesday, April 3, 2024
Principal, Harvard Medical School, Alpern, Public, Public health, FICS, Private practice, Telecanthus, Patient, DED, MPH, Therapy, FACS, Frustration, Ophthalmology, Pharmaceutical industry

“Dr.

Key Points: 
  • “Dr.
  • Alpern brings extensive real-world clinical experience treating patients with ocular surface disease, having prescribed or trialed virtually every dry eye treatment available,” said Anil Asrani, President and CEO of TearSolutions.
  • “Dr.
  • He received his Doctor of Medicine from Harvard Medical School and his Master of Public Health from the Harvard School of Public Health.

Retiree Shareowners at Verizon Push Clawback Policy & Transparency on Lead Cables Hazard

Retrieved on: 
Tuesday, April 2, 2024
Risk, Public, SPRING, Policy, Item, Justice, VZ, The Wall Street Journal, Cryptocurrency

have two shareholder proposals that will be voted on at the 2024 Verizon ( NYSE: VZ ) annual shareowner meeting taking place on May 9, 2024 .

Key Points: 
  • have two shareholder proposals that will be voted on at the 2024 Verizon ( NYSE: VZ ) annual shareowner meeting taking place on May 9, 2024 .
  • The first centers on the senior executive clawback policy and the second targets lead cables.
  • The BellTel Retirees have a long track record of acting as an integral check for better governance practices .
  • The first retiree proposal, which gained 37.9% of the vote in 2023, proposes to amend Verizon’s Senior Executive Compensation Clawback Policy ( Item #6 ).

BioCorRx Reports Business Update for 2023

Retrieved on: 
Tuesday, April 2, 2024
Annual report, Substance abuse, Bupropion, CFO, Risk, Public, OUD, Research, Security (finance), Opioid use disorder, NIH, Naltrexone, Bangladesh Technical Education Board, MUD, OTCQB, Pharmaceutical industry

ANAHEIM, CA, April 02, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the year ended December 31, 2023, and reported on recent corporate developments.

Key Points: 
  • ANAHEIM, CA, April 02, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the year ended December 31, 2023, and reported on recent corporate developments.
  • Lourdes Felix, CEO, CFO, and Director of BioCorRx Inc., commented, “In 2023, we made significant strides in advancing the Phase I clinical trial of BICX104, an implantable biodegradable naltrexone pellet designed for treating opioid use disorder (OUD).
  • We successfully decreased our total operating expenses by over $1.0 million for the year ending December 31, 2023, compared to the previous year.
  • Overall, we are optimistic about the business outlook and look forward to continuing to develop medicines.

Lotus Data Group Kicks Off SENDW3 Token Private Placement

Retrieved on: 
Tuesday, April 2, 2024
Public, Private, AI, ICO, Data management, Ecosystem, Cryptocurrency

Las Vegas, NV, April 02, 2024 (GLOBE NEWSWIRE) -- Lotus Data Group today announces the commencement of the private placement for the SENDW3 token, marking a pivotal moment in the evolution of blockchain-based data storage solutions.

Key Points: 
  • Las Vegas, NV, April 02, 2024 (GLOBE NEWSWIRE) -- Lotus Data Group today announces the commencement of the private placement for the SENDW3 token, marking a pivotal moment in the evolution of blockchain-based data storage solutions.
  • By melding the strengths of Web2 and Web3 storage and unlocking new potentials for data monetization through AI, the SENDW3 token is poised to redefine industry benchmarks," Neil Sumaru, Co-founder and Chairman of Lotus Data Group, elaborated on the vision behind the token.
  • Revolutionizing Data Management: The SENDW3 ecosystem is designed to simplify the transition to decentralized storage, markedly improve data security, and lower the costs associated with data storage.
  • The SENDW3 token is not just a tool for data storage – it's a beacon for the future of secure, efficient, accessible, and applicable data management across the globe," Thomas Hsu, CEO of Lotus Data Group, stated.

Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.

Retrieved on: 
Tuesday, April 2, 2024
Infection, OTCQX, Therapy, Bank, LZH, Arrangement, Calendar, Health, Public, Research, News, Acquisition, TSX, Drug development, Population health, Canada Business Corporations Act, Transaction, Growth, Entrepreneurship, Share, Procurement, CDN, Security (finance)

HALIFAX, Nova Scotia, April 02, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (“Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced that it has entered into a definitive arrangement agreement (the "Arrangement Agreement") pursuant to which Aditxt Inc. (NASDAQ: ADTX) (“Aditxt”), a Richmond, Virginia- based company dedicated to discovering, developing, and deploying promising health innovation, through its wholly-owned subsidiary, Adivir, Inc. (“Adivir” or the “Buyer”), agreed to acquire all of the issued and outstanding Class A common shares (the "Appili Shares") of Appili by way of a court-approved plan of arrangement under the Canada Business Corporations Act (the "Transaction").

Key Points: 
  • We welcome this new chapter, confident that together, we will achieve even greater heights in deploying innovative healthcare solutions.” said Dr. Don Cilla, President and CEO of Appili Therapeutics.
  • Under the terms of the Arrangement Agreement, Adivir will acquire all of the issued and outstanding Appili Shares, with each Appili Shareholder receiving the Transaction Consideration.
  • The Transaction is subject to the approval of at least two-thirds of the votes cast by the Appili Shareholders at the Appili Meeting.
  • Bloom Burton Securities Inc. acted as financial advisor to the Appili Board and BDO Canada LLP acted as independent financial advisor to the Appili Special Committee.

REGENESIS Launches SourceStop®, Completing World’s First Full-Spectrum In Situ PFAS Remediation Suite

Retrieved on: 
Tuesday, April 2, 2024
PFAS, Environment, Risk, SAN, Public, Groundwater, Carbon, CAC, Airport, Soil, Environmental remediation

In recent years, eliminating PFAS exposure risk has become a global priority, prompting new regulations that aim to safeguard public health and the environment.

Key Points: 
  • In recent years, eliminating PFAS exposure risk has become a global priority, prompting new regulations that aim to safeguard public health and the environment.
  • REGENESIS has been treating a wide range of contaminants – including chlorinated solvents, petroleum hydrocarbons, and PFAS – in soil and groundwater for three decades.
  • Pairing these solutions unlocks the world’s first end-to-end, in situ PFAS remediation approach.
  • For more information about how SourceStop effectively addresses PFAS, please visit www.pfastreatment.org or reach out to your regional technical representative.